高级检索
当前位置: 首页 > 详情页

Multicenter prospective study of magnetic resonance imaging prior to breast-conserving surgery for breast cancer

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE ◇ 统计源期刊 ◇ CSCD-C ◇ 中华系列

单位: [1]Peking Univ, Hosp 1, Breast Dis Ctr, Dept Gen Surg, Beijing 100034, Peoples R China [2]Peking Univ, Hosp 1, Breast Dis Ctr, Dept Oncol, Beijing 100034, Peoples R China [3]Peking Univ, Hosp 1, Breast Dis Ctr, Dept Pathol, Beijing 100034, Peoples R China [4]Peking Univ, Hosp 1, Breast Dis Ctr, Dept Radiol, Beijing 100034, Peoples R China [5]Capital Med Univ, Xuanwu Hosp, Breast Dis Ctr, Dept Gen Surg, Beijing 100053, Peoples R China [6]Beijing Chao Yang Hosp, Dept Gen Surg, Breast Dis Ctr, Beijing 100020, Peoples R China [7]Peking Univ, Peoples Hosp, Breast Dis Ctr, Dept Gen Surg, Beijing 100044, Peoples R China [8]Capital Med Univ, Beijing Friendship Hosp, Dept Gen Surg, Breast Dis Ctr, Beijing 100050, Peoples R China [9]Peoples Liberat Army, Hosp 307, Breast Dis Ctr, Dept Oncol, Beijing 100071, Peoples R China [10]Peoples Liberat Army, Hosp 307, Breast Dis Ctr, Dept Gen Surg, Beijing 100071, Peoples R China
出处:
ISSN:

关键词: breast cancer magnetic resonance imaging histopathology breast-conserving surgery

摘要:
Background This multicenter prospective study aimed to assess the utility of dynamic enhanced magnetic resonance imaging (MRI) prior to breast-conserving surgery for breast cancer. Methods The research subjects were drawn from patients with primary early resectable breast cancer treated in the breast disease centers of six three-level hospitals in Beijing from 1 January 2010 to 31 December 2012. The participants were allocated to a breast-conserving surgery group (breast-conserving group) or a total mastectomy group (total mastectomy group). Enhanced MRI was used to measure breast volume, longest diameter of tumor and tumor volume. The correlations between these measurements and those derived from histopathologic findings were assessed. The relationships between the success rate of breast-conserving surgery and MRI- and pathology-based measurement results were statistically analyzed in the breast-conserving group. Results The study included 461 cases in the total mastectomy group and 195 in the breast-conserving group. Allocation to these groups was based on clinical indications and patient preferences. The cut-off for concurrence between MRI- and pathology-based measurements of the longest diameter of tumor was set at 0.3 cm. In the total mastectomy group, the confidence interval for 95% concurrence of these measurements was 35.41%-44.63%. Correlation coefficients for MRI and histopathology-based measurements of breast volume, tumor volume and tumor volume/breast volume ratio were r=0.861, 0.569, and 0.600, respectively (all P <0.001). In the breast-conserving group, with 0.30 cm taken as the cut-off for concurrence, the 95% confidence interval for MRI and pathology-based measurements of the longest diameter of tumor was 29.98%-44.01%. The subjective and objective success rates for breast-conserving surgery were 100% and 88.54%, respectively. Conclusions There were significant correlations between dynamic enhanced MRI- and histopathology-based measurements of the longest diameter of breast lesions, breast and tumor volumes, and breast volume/tumor volume ratios. Preoperative MRI examination improves the success rate of breast-conserving surgery.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2013]版:
大类 | 4 区 医学
小类 | 4 区 医学:内科
最新[2025]版:
大类 | 2 区 医学
小类 | 2 区 医学:内科
JCR分区:
出版当年[2012]版:
Q3 MEDICINE, GENERAL & INTERNAL
最新[2023]版:
Q1 MEDICINE, GENERAL & INTERNAL

影响因子: 最新[2023版] 最新五年平均[2021-2025] 出版当年[2012版] 出版当年五年平均[2008-2012] 出版前一年[2011版] 出版后一年[2013版]

第一作者:
第一作者单位: [1]Peking Univ, Hosp 1, Breast Dis Ctr, Dept Gen Surg, Beijing 100034, Peoples R China
通讯作者:
通讯机构: [1]Peking Univ, Hosp 1, Breast Dis Ctr, Dept Gen Surg, Beijing 100034, Peoples R China [*1]Peking Univ, Hosp 1, Breast Dis Ctr, Beijing 100034, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:1320 今日访问量:0 总访问量:816 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)